TradingView
Barkworth
Sep 10, 2019 6:51 AM

CARA in equilibrium Short

NASDAQ:CARA1D
Cara Therapeutics, Inc.NASDAQ

Description

⋅
Initial spike in volume was caused by fast track and phase 3 news. Nothing to drive the price at the moment. My best best is that we'll see CARA retest $19.65 within a week or so.
Trend AnalysisChart PatternsWave AnalysisCARA
More